Cell Medica's Series B - II Round

Cell Medica raised a round of funding on November 25, 2014.

Cell Medica develops, manufactures and markets cellular immunotherapy products for the treatment of cancer and infections. The Company employs technologies to develop cell-based therapies with the pot…

Articles about Cell Medica's Series B - II Round: